Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_564388736955269806e7cb0a216326b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9be95030f7e9b1f0dc582614a74096d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79be7429808968113d4d0ed758513f63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d57fcdda5269527abd0a62f03aafb1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5fe40eda58ae8c7c63ace8549d1591e5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20220dedc5dbec6c5c5d185fe5cdd516 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-32 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-111 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
filingDate |
2013-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5160bd80f34dc2bfddc31f8492cb584 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3aca803eb7fb9c785ca14bac4eaf7c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93053e22cba184f697f82d8e958d9774 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3932e76e8856e705e1c8bee1c9c02f5b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de6cf0e6ac3932e9363e359bbe4a66ed http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6567060ebb2e24332db2b69b0c95276 |
publicationDate |
2016-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-9295640-B2 |
titleOfInvention |
Pharmaceutical composition for treating cancer using carbonate apatite nanoparticles |
abstract |
A principal object of the present invention is to provide a pharmaceutical composition that can produce a high antitumor effect by efficiently delivering a drug with antitumor activity to tumor tissues with the aid of carbonate apatite nanoparticles. The present invention provides a pharmaceutical composition including carbonate apatite nanoparticles with an average particle size of at most 50 nm containing a drug with antitumor activity and a pharmacologically acceptable solvent in which the carbonate apatite nanoparticles containing the drug are dispersed. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018360964-A1 |
priorityDate |
2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |